ImmunologybioRxivPreprint
Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection
A. C. Moore, E. G. Dora, N. Peinovich…·S. Tucker
This study evaluates mucosal adenovirus vaccines against SARS-CoV-2, showing that full-length spike antigen induces stronger neutralizing antibodies and T-cell responses compared to partial antigens in mice.
DOI 10.1101/2020.09.04.283853